Cargando…

mRNA COVID-19 vaccine is well tolerated in patients with cutaneous and systemic mastocytosis with mast cell activation symptoms and anaphylaxis

Detalles Bibliográficos
Autores principales:	Rama, Tiago Azenha, Moreira, André, Castells, Mariana
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Academy of Allergy, Asthma & Immunology 2021
Materias:	Covid-19
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7816615/ https://www.ncbi.nlm.nih.gov/pubmed/33485650 http://dx.doi.org/10.1016/j.jaci.2021.01.004

Ejemplares similares

Potential mechanisms of anaphylaxis to COVID-19 mRNA vaccines
por: Risma, Kimberly A., et al.
Publicado: (2021)

COVID-19 infection in patients with mast cell disorders including mastocytosis does not impact mast cell activation symptoms
por: Giannetti, Matthew P., et al.
Publicado: (2021)

Mastocytosis presenting with mast cell‐mediator release‐associated symptoms elicited by cyclo oxygenase inhibitors: prevalence, clinical, and laboratory features
por: Rama, Tiago Azenha, et al.
Publicado: (2022)

Clinicopathological features of cutaneous reactions after mRNA‐based COVID‐19 vaccines
por: Tihy, M., et al.
Publicado: (2021)

A Puzzling Mast Cell Trilogy: Anaphylaxis, MCAS, and Mastocytosis
por: Gülen, Theo
Publicado: (2023)

Mediator-Related Symptoms and Anaphylaxis in Children with Mastocytosis
por: Brockow, Knut, et al.
Publicado: (2021)

Anaphylaxis to the first COVID-19 vaccine: is polyethylene glycol (PEG) the culprit?
por: Garvey, Lene H., et al.
Publicado: (2021)

Clinical presentation and markers of cutaneous versus systemic mastocytosis: the mastocytosis center at brigham and women's hospital in Boston
por: Kanamori, Kelly Yoshimi, et al.
Publicado: (2015)

Case Report: Mastocytosis: The Long Road to Diagnosis
por: Rama, Tiago Azenha, et al.
Publicado: (2021)

Cerebral venous sinus thrombosis after mRNA-based COVID-19 vaccination
por: Yagi, Yohsuke, et al.
Publicado: (2021)

Humoral response to mRNA‐based COVID‐19 vaccine in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2022)

Fatal Hymenoptera Venom–Triggered Anaphylaxis in Patients with Unrecognized Clonal Mast Cell Disorder—Is Mastocytosis to Blame?
por: Rijavec, Matija, et al.
Publicado: (2023)

Immunogenicity of the mRNA-1273 COVID-19 vaccine in adult patients with inborn errors of immunity
por: van Leeuwen, Leanne P.M., et al.
Publicado: (2022)

Aseptic meningitis after vaccination of the BNT162b2 mRNA COVID-19 vaccine
por: Saito, Kazuyuki, et al.
Publicado: (2021)

A case of anti-MOG antibody-positive ADEM following COVID-19 mRNA vaccination
por: Miyamoto, Katsuichi, et al.
Publicado: (2022)

Spinal cord ischemia complicating BNT162b2 mRNA COVID-19 vaccination
por: Fotiadou, Aggeliki, et al.
Publicado: (2022)

COVID-19 Symptoms Can Prolong Seasonal Flu Infection Symptoms and Recovery Times Among Obese African American Female Population
por: Asare, Smart, et al.
Publicado: (2021)

A Symptom-Based Rule for Diagnosis of COVID-19
por: Smith, David S., et al.
Publicado: (2020)

COVID-19 and Pregnancy: Risk, Symptoms, Diagnosis, and Treatment
por: Hapshy, Vera, et al.
Publicado: (2021)

Optimizing COVID-19 Symptom Screening in the Pediatric Population
por: Zhou, Geena, et al.
Publicado: (2021)

Cardiac magnetic resonance characteristics of acute myocarditis occurring after mRNA-based COVID-19 vaccines immunization
por: Meyer-Szary, Jaroslaw, et al.
Publicado: (2022)

New-onset myasthenia gravis after mRNA SARS-CoV-2 vaccination: a case series
por: Fanella, Gaia, et al.
Publicado: (2022)

Impact of Gastrointestinal Symptoms in COVID-19: a Molecular Approach
por: Sonkar, Charu, et al.
Publicado: (2020)

Characteristics, onset, and evolution of neurological symptoms in patients with COVID-19
por: Kacem, Imen, et al.
Publicado: (2020)

Symptoms and Clinical Outcomes of Coronavirus Disease 2019 in the Outpatient Setting
por: Knight, Dacre, et al.
Publicado: (2021)

COVID-19 infection and Down syndrome—challenges and future directions for care in children
por: Chauhan, Kaushambi, et al.
Publicado: (2022)

Dyspnea perception and neurological symptoms in non-severe COVID-19 patients
por: Ora, Josuel, et al.
Publicado: (2020)

The importance of early detection of ENT symptoms in mild-to-moderate COVID-19
por: Spinato, Giacomo, et al.
Publicado: (2021)

Immunogenicity and tolerability of COVID-19 messenger RNA vaccines in primary immunodeficiency patients with functional B-cell defects
por: Pham, Michele N., et al.
Publicado: (2022)

“Palliative Pandemic Plan,” Triage and Symptoms Algorithm as a Strategy to Decrease Providers’ Exposure, While Trying to Increase Teams Availability and Guidance for Goals of Care (GOC) and Symptoms Control
por: Lopez, Santiago, et al.
Publicado: (2020)

Preliminary evidence of blunted humoral response to SARS-CoV-2 mRNA vaccine in multiple sclerosis patients treated with ocrelizumab
por: Gallo, Antonio, et al.
Publicado: (2021)

How well do covariates perform when adjusting for sampling bias in online COVID-19 research? Insights from multiverse analyses
por: Joyal-Desmarais, Keven, et al.
Publicado: (2022)

First motor seizure as presenting symptom of SARS-CoV-2 infection
por: Fasano, Antonio, et al.
Publicado: (2020)

The Association Between Symptoms and COVID-19 Test Results Among Healthcare Workers
por: Sacks, Chana A., et al.
Publicado: (2020)

Nutritional intake and gastro-intestinal symptoms in critically ill COVID-19 patients
por: Lakenman, P.L.M., et al.
Publicado: (2022)

Symptoms of gait and coordination impairment in a patient with COVID-19 interstitial pneumonia
por: Pistoia, Francesca, et al.
Publicado: (2021)

Six-month humoral response to BNT162b2 mRNA COVID-19 vaccine in people with multiple sclerosis treated with natalizumab
por: Altieri, Manuela, et al.
Publicado: (2022)

COV-BT Ire study: safety and efficacy of the BNT162b2 mRNA COVID-19 vaccine in patients with brain tumors
por: Tanzilli, Antonio, et al.
Publicado: (2022)

T‐cell immune response after mRNA SARS‐CoV‐2 vaccines is frequently detected also in the absence of seroconversion in patients with lymphoid malignancies
por: Marasco, Vincenzo, et al.
Publicado: (2021)

Excess risk and clusters of symptoms after COVID-19 in a large Norwegian cohort
por: Caspersen, Ida Henriette, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_gf6ept05vs15k9eaepc66b45gc